Loading...
NPI 1952381477 · Pompano Beach, FL · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Ameripath Florida LLC is a clinical medical laboratory provider located in Pompano Beach, Florida. This profile covers 48 Medicare and 17 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Ameripath Florida LLC |
| Address | 895 Sw 30th Ave |
| City | Pompano Beach |
| State | FL |
| ZIP | 33069 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | January 19, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $9.1M |
| Medicaid | $3.5M |
AMERIPATH FLORIDA LLC presents as a high-volume clinical pathology laboratory focused on surgical pathology and immunostaining services: Medicare shows heavy billing for 88305 ($5.1M revenue, 101.2K claims, 55.6% of Medicare revenue), 88350 ($1.4M revenue, 16.3K claims, 15.9% of Medicare revenue), and 88341 ($592.2K revenue, 9K claims, 6.5% of Medicare revenue). These specific codes correspond to level IV surgical pathology reviews and immunofluorescent/antibody staining work, indicating core competency in histopathology and specialized immunohistochemistry workflows.
Medicaid billing mirrors the Medicare pattern with surgical pathology and special stains concentrated at the top: 88305 accounts for $2.1M (56.4K claims, 61.1% of Medicaid revenue) while 88312 ($336.6K, 10.2K claims, 9.6%) and 88342 ($253.9K, 7.1K claims, 7.2%) are the next largest contributors. The Medicaid top codes similarly reflect high-volume technical staining and interpretation services, consistent with a lab that processes large caseloads for tissue diagnosis under state payers.
Revenue concentration is pronounced for both payers: the precomputed top-3 codes account for 78.0% of Medicare revenue and 78.0% of Medicaid revenue. This narrow set of high-revenue codes indicates the business is highly dependent on surgical pathology and immunostain services for its payer revenue streams, which is important for payer contracting and utilization reviews.
The provider’s payer mix is Medicare-weighted in scale: Total Medicare revenue is $9.1M compared with Total Medicaid revenue of $3.5M, so Medicare represents the larger single-payer revenue source on file. Medicaid is a meaningful but smaller contributor, so the practice is not effectively single-payer but is more dependent on Medicare volume.
AMERIPATH FLORIDA’s Medicare competitive standing is nationally prominent on its top pathology codes: 88305 ranks #4 of 14580 providers nationally (100th percentile; extreme outlier) and 88350 ranks #2 of 652 providers nationally (100th percentile; extreme outlier), with several other pathology codes also at the 100th percentile. Those rank positions and the “extreme outlier” labels signal that this provider operates at volumes far above typical national peers for those services, consistent with a national-scale throughput for surgical pathology and immunostaining.
State-level competitive standing in Florida is similarly strong on Medicaid: 88305 ranks #2 of 444 providers in-state (100th percentile; extreme outlier), 88312 ranks #3 of 111 in-state (98th percentile; extreme outlier), and 88304 ranks #1 of 158 in-state (100th percentile; extreme outlier). These in-state ranks indicate the provider is a dominant Medicaid pathology supplier in Florida for several high-volume codes.
The NPI tenure indicates an established operation: NPI enumerated (registered) on 2006-01-19 (~20 years ago). Sustained enrollment combined with the high claim volumes and dominant ranks suggests long-standing referral relationships and operational capacity to process large pathology caseloads over time.
Multiple individual codes are flagged as statistical outliers, which has operational and contracting implications: codes labeled “extreme outlier” or “notably above typical” include 88305, 88350, 88312, 88304, 88341 and 88342 across Medicare and Medicaid. For payers and network planners, these concentrated outlier volumes point to a centralized diagnostic hub model—useful when assessing network adequacy, rate negotiations, and targeted utilization management for high-cost pathology services.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
48 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 88305 | The physician, typically a pathologist, performs a level IV examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 101,150 | $50 | $5.1M |
| 88350 | The analyst performs an immunofluorescent study using a single antibody stain procedure to detect autoimmune disease or an infectious organism in a tissue or cellular sample. Code +88350 describes… | 16,250 | $90 | $1.4M |
| 88341 | The lab analyst applies an additional single antibody stain on a slide or slides prepared from the same patient specimen as the initial antibody stain, such as tumor tissue. Then a qualified… | 8,970 | $70 | $592.2K |
| 88342 | The lab analyst applies an initial single antibody stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. Then a qualified provider, typically a pathologist,… | 6,690 | $80 | $514.8K |
| 88312 | The lab analyst performs the technical lab steps to stain a specimen with a special stain. This code applies to Group I for microorganisms. A qualified provider, typically a pathologist, interprets… | 4,490 | $90 | $381.4K |
| 88346 | The analyst performs an immunofluorescent study using a single antibody stain procedure to detect autoimmune disease or an infectious organism in a tissue or cellular sample. | 3,040 | $110 | $319.3K |
| 88304 | The physician, typically a pathologist, performs a level III examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 4,600 | $30 | $138.1K |
| 88307 | The physician, typically a pathologist, performs a level V examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 820 | $160 | $132.5K |
| 88112 | Selective cellular enhancement for cytopathology, such as the method of using a liquid–based slide preparation, uses a liquid–based medium to collect samples and preserve cells which can aid in… | 1,440 | $50 | $76.1K |
| G0416 | Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 250 | $290 | $70.4K |
Showing 1–10 of 48
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 48 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
48 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 88185 | 18 | 20 | 4,720 | $20 | $222.5K |
| 88237 | 5 | 10 | 140 | $140 | $175.8K |
| 88264 | 6 | 10 | 440 | $140 | $96.7K |
| 88305 | 1 | 980 | 570 | $40 | $83.5K |
| 88120 | 8 | 20 | 70 | $350 | $78K |
| 88350 | 1 | 30 | 160 | $80 | $69.9K |
| 81342 | 3 | 10 | 130 | $200 | $60.9K |
| 81340 | 3 | 10 | 140 | $200 | $52.8K |
| 88184 | 15 | 20 | 270 | $60 | $31.7K |
| 88312 | 6 | 510 | 70 | $60 | $24K |
Showing 1–10 of 48
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
17 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 88305 | The physician, typically a pathologist, performs a level IV examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 56,400 | $40 | $2.1M |
| 88312 | The lab analyst performs the technical lab steps to stain a specimen with a special stain. This code applies to Group I for microorganisms. A qualified provider, typically a pathologist, interprets… | 10,200 | $30 | $336.6K |
| 88342 | The lab analyst applies an initial single antibody stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. Then a qualified provider, typically a pathologist,… | 7,050 | $40 | $253.9K |
| 88313 | The lab analyst performs the technical lab steps to stain a specimen for Group II identification, for example an iron stain or trichrome stain. A qualified provider, typically a pathologist,… | 2,570 | $90 | $221.4K |
| 88350 | The analyst performs an immunofluorescent study using a single antibody stain procedure to detect autoimmune disease or an infectious organism in a tissue or cellular sample. Code +88350 describes… | 2,640 | $60 | $161K |
| 88304 | The physician, typically a pathologist, performs a level III examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 9,960 | $20 | $159.4K |
| 88341 | The lab analyst applies an additional single antibody stain on a slide or slides prepared from the same patient specimen as the initial antibody stain, such as tumor tissue. Then a qualified… | 1,960 | $60 | $117.8K |
| 88346 | The analyst performs an immunofluorescent study using a single antibody stain procedure to detect autoimmune disease or an infectious organism in a tissue or cellular sample. | 2,590 | $20 | $49.2K |
| 88307 | The physician, typically a pathologist, performs a level V examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 1,020 | $30 | $33.7K |
| 88344 | The lab analyst applies a single multiplex antibody stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. Then a qualified provider, typically a pathologist,… | 240 | $50 | $11.7K |
Showing 1–10 of 17
How this provider's Medicaid billing volume and revenue compare to other Florida providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Florida median
17 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 88185 | The lab analyst performs the technical component of a flow cytometry procedure using cell surface, cytoplasmic, or nuclear markers to characterize cells and aid clinicians in diagnosing patients with… | 23 | 30 | 590 | $70 | $119.3K |
| 88305 | The physician, typically a pathologist, performs a level IV examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 2 | 440 | 610 | $40 | $111.5K |
| 88307 | The physician, typically a pathologist, performs a level V examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 28 | 120 | 180 | $50 | $63.4K |
| 88350 | The analyst performs an immunofluorescent study using a single antibody stain procedure to detect autoimmune disease or an infectious organism in a tissue or cellular sample. Code +88350 describes… | 1 | 10 | 1,270 | $40 | $54.6K |
| 88237 | The lab analyst performs a procedure to grow a culture of cells from bone marrow or blood in a neoplastic disorder. | 10 | 10 | 60 | $40 | $32.9K |
| 88312 | The lab analyst performs the technical lab steps to stain a specimen with a special stain. This code applies to Group I for microorganisms. A qualified provider, typically a pathologist, interprets… | 3 | 110 | 210 | $30 | $31.8K |
| 88184 | The lab analyst performs the technical component of a flow cytometry procedure using a cell surface, cytoplasmic, or nuclear marker to characterize cells and aid clinicians in diagnosing patients… | 26 | 30 | 260 | $20 | $24.4K |
| 88341 | The lab analyst applies an additional single antibody stain on a slide or slides prepared from the same patient specimen as the initial antibody stain, such as tumor tissue. Then a qualified… | 7 | 70 | 160 | $30 | $24.1K |
| 88189 | The clinician, typically a pathologist, interprets flow cytometry results of 16 or more markers. | 18 | 20 | 250 | $30 | $19.4K |
| 88342 | The lab analyst applies an initial single antibody stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. Then a qualified provider, typically a pathologist,… | 4 | 190 | 180 | $20 | $15.6K |
Showing 1–10 of 17
Other providers in the same ZIP code as Ameripath Florida LLC, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Adw Diabetes LLC | FL | Durable Medical Equipment & Medical Supplies | $0 | $34.8M |
| Pathology On The Go Inc. | FL | Clinical Medical Laboratory | $2.5M | $437.6K |
| Broward Ambulance Inc | FL | Ambulance | $1.1M | $1.6M |
| Daniel Brandwein | FL | Podiatrist | $1.3M | $0 |
| Metro Treatment Of Florida, LP | FL | Methadone Clinic | $102.6K | $481.3K |
| Marlon Osbourne | FL | Anatomic Pathology Physician | $355.1K | $0 |
| Linda Hughes | FL | Vascular & Interventional Radiology Physician | $126.7K | $0 |
| Stephen Kadet | FL | Anesthesiology Physician | $45.3K | $0 |
| Reed Hofmann | FL | Anesthesiologist Assistant | $10.8K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.